1981 · 33 citations · 10 references
Life SciencesImmunologyOphthalmologyAutoimmunityImmunotherapyOcular ImmunologyAutoantigensAutoimmune DiseasesAutoimmune Eye DiseaseAutoimmune Ocular DiseaseCell-mediated ImmunityOcular InflammationImmune-mediated UveitisImmunosuppressive Therapy For UveitisOcular AutoimmunityT Cell-mediated Ocular InflammationT Cell-mediated Retinal InflammationT-cell Mediated ImmunityT-cell Mediated Ocular InflammationUveitis Pharmacotherapy
A B S T R A C T Cyclosporin A (CS-A), a selective inhibitor of T lymphocytes, is reported here to prevent S antigen (S-Ag) induced uveitis in Lewis rats. The S-Ag, found in all mammalian retinas, is uveitogenic under experimental conditions and patients with certain uveitic entities demonstrate cell mediated responses to this antigen. Daily treatment with CS-A (10 mg/kg) begun on the same day as S-Ag immunization totally inhibited the development of the uveitis in this experimental autoimmune model. Moreover a greater CS-A dose (40 mg/kg) efficiently prevented the disease process when therapy was started 7 d after S-Ag immunization. Anti-S-Ag antibody titers were observed to be similar in rats either protected or not protected with CS-A. Our data support strongly the need forT cell participation in this disease model. Since ocular inflammatory disease is an important cause of visual impairment, the data further suggest that CS-A may be useful in the treatment of patients with intractable uveitis.
10
Biological effects of cyclosporin A: A new antilymphocytic agent
J. F. Borel, Camille Feurer, H. U. Gubler et al. · Inflammation Research · 1976 · 1.5K citations
Enzyme-linked immunoassay (ELISA) for connective tissue components
Stephen I. Rennard, R A Berg, George R. Martin et al. · Analytical Biochemistry · 1980 · 607 citations
Allan D. Hess, P. J. Tutschka · The Journal of Immunology · 1980 · 236 citations